Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians. OBJECTIVE: To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacological management of NeP to develop a revised evidence‐based consensus statement on its management. METHODS: RCTs, systematic reviews and existing guidelines on the pharmacological management of NeP were evaluated at a consensus meeting in May 2012 and updated until September 2013. Medications were recommended in the consensus statement if their analgesic efficacy was supported by at least one methodologically sound RCT (class I or class II) showing significant benefit relative to placebo or another relevant control group. Recommendations for treatment were based on the degree of evidence of analgesic efficacy, safety and ease of use. RESULTS: Analgesic agents recommended for first‐line treatments are gabapentinoids (gabapentin and pregabalin), tricyclic antidepressants and serotonin noradrenaline reuptake inhibitors. Tramadol and controlled‐release opioid analgesics are recommended as second‐line treatments for moderate to severe pain. Cannabinoids are now recommended as third‐line treatments. Recommended fourth‐line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacos‐amide), tapentadol and botulinum toxin. There is support for some analgesic combinations in selected NeP conditions. CONCLUSIONS: These guidelines provide an updated, stepwise approach to the pharmacological management of NeP. Treatment should be individualized for each patient based on efficacy, side‐effect profile and drug accessibility, including cost. Additional studies are required to examine head‐to‐head comparisons among analgesics, combinations of analgesics, long‐term outcomes and treatment of pediatric, geriatric and central NeP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Results from both the scientific literature and public media revealed few references to nabilone abuse.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, nabilone theft did occur, although nabilone has no known street value.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“According to the literature, the positive side effects (euphoria, mood elevation) of nabilone, which may lead to abuse, generally occurred less frequently than the negative side effects (drowsiness, dizziness, and dry mouth).”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the public media, patients described nabilone as not producing the same therapeutic and recreational effects as smoked cannabis.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Overall, the authors concluded that nabilone is rarely abused or diverted.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Ginies, P., Grun-Overdyking, A., et al. (2005) · Pain · doi:10.1016/j.pain.2004.12.010 · Cited by 2,741
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
Max, M. B., Lynch, S. A., Muir, J., Shoaf, S. E., Smoller, B., & Dubner, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261904 · Cited by 1,117
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Research works printed but not linked: 1
- [20]Cohen J Statistical Power Analysis for the Behavioural Sciences New York, San Francisco, London Academic Press 1988
Cited by
Items 201–300 of 529
Ai, N., Wood, R. D., Yang, E., & Welsh, W. J. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2027-9 · Cited by 19
Tyree, G. A., Sarkar, R. R., Bellows, B. K., Ellis, R. J., Atkinson, J. H., Marcotte, T. D., Wallace, M. S., Grant, I., Shi, Y., Murphy, J. D., et al. (2019) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0027 · Cited by 17
Jonassaint, C. R., Rao, N., Sciuto, A., Switzer, G. E., Castro, L. M. D., Kato, G. J., Jonassaint, J., Hammal, Z., Shah, N., & Wasan, A. D. (2018) · Journal of Medical Internet Research · doi:10.2196/10056 · Cited by 22
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults
Wiffen, P. J., Knaggs, R., Derry, S., Cole, P., Phillips, T., & Moore, R. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012227 · Cited by 18
Management of Chronic Pain in Elderly Patients: The Central Role of Nurses in Multidisciplinary Care
Markovics, D., Virág, A., & Gadó, K. (2025) · Geriatrics · doi:10.3390/geriatrics10040110 · Cited by 21
New Developments in the Pharmacotherapy of Neuropathic Chronic Pelvic Pain
Carey, E. T., & As‐Sanie, S. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0048 · Cited by 18
Suzuki, M., Millecamps, M., Naso, L., Ohtori, S., Mori, C., & Stone, L. S. (2017) · Journal of Osteoporosis · doi:10.1155/2017/7582716 · Cited by 21
Yamamoto, P. A., Costa, A., Lauretti, G. R., & de Moraes, N. V. (2019) · Pharmacogenomics · doi:10.2217/pgs-2019-0066 · Cited by 23
Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome
Suga, T., Takenoshita, M., Watanabe, T., Tu, T. T. H., Mikuzuki, L., Hong, C., Miura, K., Yoshikawa, T., Nagamine, T., & Toyofuku, A. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s235669 · Cited by 22
The Italian Consensus Conference on Pain in Neurorehabilitation: rationale and methodology
Tamburin, S., Paolucci, S., Magrinelli, F., Musicco, M., & Sandrini, G. (2016) · Journal of Pain Research · doi:10.2147/jpr.s84646 · Cited by 18
Canadian Urological Association best practice report on chronic scrotal pain
Jarvi, K. A., Wu, C. L., Nickel, J. C., Domes, T., Grantmyre, J. E., & Zini, A. S. (2018) · Canadian Urological Association Journal · doi:10.5489/cuaj.5238 · Cited by 21
Katta-Charles, S. (2020) · Neurorehabilitation · doi:10.3233/nre-208004 · Cited by 17
Current and future pharmacological agents for the treatment of back pain
Bhatia, A., Engle, A. M., & Cohen, S. P. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1735353 · Cited by 32
Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients
Ajrawat, P., Yang, Y., Wasilewski, E., Leroux, T. S., Ladha, K. S., Bhatia, A., Singh, M., Thaker, S., Kapoor, M., Furlan, A. D., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0143 · Cited by 63
Self-citationLafreniere, J. D., & Kelly, M. E. M. (2018) · Neuronal Signaling · doi:10.1042/ns20170144 · Cited by 18
Sundaram, S., & Punj, J. (2019) · Pain Medicine · doi:10.1093/pm/pnz370 · Cited by 15
Guenter, D., Abouzahra, M., Schabort, I., Radhakrishnan, A., Nair, K., Orr, S., Langevin, J., Taenzer, P. A., & Moulin, D. E. (2019) · JMIR Medical Informatics · doi:10.2196/14141 · Cited by 15
Self-citationPharmacotherapeutic Management of Neuropathic Pain in End-Stage Renal Disease
Raouf, M., Bettinger, J. J., Wegrzyn, E., Mathew, R. O., & Fudin, J. (2020) · Kidney Diseases · doi:10.1159/000504299 · Cited by 19
Diagnostik und Therapie neuropathischer Schmerzen
Goßrau, G., & Sabatowski, R. (2021) · Der Anaesthesist · doi:10.1007/s00101-021-01039-x · Cited by 16
Windsor, R. B., Sierra, M., Zappitelli, M. W., & McDaniel, M. (2020) · Children · doi:10.3390/children7120268 · Cited by 16
Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain
Xantus, G. Z., Závori, L., Matheson, C., Gyarmathy, V. A., Fazekas, L. M., & Kanizsai, P. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1917379 · Cited by 14
The Pharmacological Treatment of Neuropathic Pain in Children
Einhorn, L. M., Hudon, J., & Ingelmo, P. M. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230804110858 · Cited by 15
Prevalence of neuropathic pain in patients with cancer
Couceiro, T. C. D. M., Lima, L. C., Júnior, M. P. C., Mello, P. F. D. L. S. D. O., Ferreira, T. M. M. L., & Firmino, A. L. P. (2018) · Brazilian Journal Of Pain · doi:10.5935/2595-0118.20180045 · Cited by 14
Xiao, H., Ma, K., Huang, D., Liu, X., Liu, T., Liu, Q., Liu, G., Song, T., Tao, W., Wu, D., et al. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i9.2100 · Cited by 14
Borgonetti, V., Anceschi, L., Brighenti, V., Corsi, L., Governa, P., Manetti, F., Pellati, F., & Galeotti, N. (2022) · Phytotherapy Research · doi:10.1002/ptr.7710 · Cited by 17
Santis, S. D., Borghesi, C., Ricciardi, S., Giovannoni, D., Fulvi, A., Migliorino, M. R., & Marcassa, C. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s108144 · Cited by 18
Pregabalin and injury: A nested case‐control and case‐crossover study
Miyamoto, Y., Iwagami, M., Aso, S., Matsui, H., Doi, K., & Yasunaga, H. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4976 · Cited by 15
An overview of the non‐procedural treatment options for peripheral neuropathic pain
Zeldin, E. R., Goddard, A. R., Boyle, M. S., Madathil, R. L., Rosenvall, E., Majithia, K. A., & Morrison, E. (2024) · Muscle & Nerve · doi:10.1002/mus.28286 · Cited by 14
Analgesia, sedation, and delirium in pediatric surgical critical care
Cunningham, M. E., & Vogel, A. M. (2019) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2019.01.006 · Cited by 13
Fu, Y., Gong, C., Zhu, C., Zhong, W., Guo, J., & Chen, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1182411 · Cited by 15
Dantas, J. M., Oliveira, M. D. J., Silva, L. A. O., Batista, S., Dagostin, C. S., & Schachter, D. C. (2023) · Clinical Drug Investigation · doi:10.1007/s40261-023-01318-y · Cited by 14
The State of Synthetic Cannabinoid Medications for the Treatment of Pain
Maglaviceanu, A., Peer, M., Rockel, J. S., Bonin, R. P., Fitzcharles, M., Ladha, K. S., Bhatia, A., Leroux, T. S., Kotra, L. P., Kapoor, M., et al. (2024) · CNS Drugs · doi:10.1007/s40263-024-01098-9 · Cited by 17
Self-citationSubedi, A., Chaudakshetrin, P., Chotisukarat, H., & Mandee, S. (2016) · Journal of Clinical Neurology · doi:10.3988/jcn.2016.12.4.489 · Cited by 13
Shakshuki, A., Yeung, P. K. F., & Agu, R. U. (2020) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v73i2.2979 · Cited by 15
Topical Fixed-Dose Combinations: A Way of Progress for Pain Management?
Veloso, C., Cardoso, C., & Vitorino, C. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.06.009 · Cited by 13
Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine
Balogh, M., Janjic, J. M., & Shepherd, A. J. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0123 · Cited by 13
The Influence of Dietary Supplementations on Neuropathic Pain
D’Egidio, F., Lombardozzi, G., Kacem, H., Mastroiacovo, G., Alfonsetti, M., & Cimini, A. (2022) · Life · doi:10.3390/life12081125 · Cited by 19
Cannabinoids in the management of chronic pain: a front line clinical perspective
Lynch, M. E. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0059 · Cited by 13
Pain in Patients with Dystrophic Epidermolysis Bullosa: Association with Anxiety and Depression
Fortuna, G., Aria, M., Cepeda‐Valdes, R., Moreno‐Treviño, M. G., & Salas-Alanis, J. C. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.6.746 · Cited by 15
Rozworska, K. A., Poulin, P. A., Carson, A., Tasca, G. A., & Nathan, H. J. (2019) · Journal of Behavioral Medicine · doi:10.1007/s10865-019-00079-4 · Cited by 16
Nielsen, S., Gisev, N., Leung, J., Clare, P. J., Bruno, R., Lintzeris, N., Larance, B., Blyth, F., Hall, W., Cohen, M. L., et al. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14715 · Cited by 14
Chen, H., Mohsin, M., Ge, J.-Y., Feng, Y., Wang, J., Ou, Y.-S., Jiang, Z., Hu, B.-Y., & Liu, X. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00254 · Cited by 13
Yang, F., Wang, Y., Zhang, M., & Yu, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1491570 · Cited by 13
Recommendations for Pharmacologic Therapy of Neuropathic Pain
Haroutounian, S., & Finnerup, N. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40196-8.00050-4 · Cited by 14
Stability of gabapentin in extemporaneously compounded oral suspensions
Friciu, M., Roullin, G., & Leclair, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175208 · Cited by 12
Amitriptyline Therapy in Chronic Pain
Su, M. (2015) · International Archives of Clinical Pharmacology · doi:10.23937/2572-3987.1510001 · Cited by 12
Shaheen, A., Alam, S. M., Ahmad, A., & Khan, M. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.35.6.652 · Cited by 14
Liang, H., Coyle, M., Wang, K., Zhang, A. L., Guo, X., Li, H., Xue, C. C., & Lu, C. (2017) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2017.01.005 · Cited by 12
Wound Pain Management: The Present and the Future
Lee, K., Lee, S., & Kim, J.-S. (2024) · Journal of Wound Management and Research · doi:10.22467/jwmr.2024.03153 · Cited by 18
Shrikhande, A., Ullger, C., Seko, K., Patil, S., Natarajan, J., Tailor, Y., & Thompson-Chudy, C. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000949 · Cited by 17
The Use of Opioids for Treatment of Pediatric Neuropathic Pain: A Literature Review
Windsor, R. B., Tham, S. W., Adams, T. L., & Anderson, A. C. (2019) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000712 · Cited by 11
Sollie, M., Thomsen, J. B., & Sørensen, J. A. (2020) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2020.08.038 · Cited by 12
Boivin, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_17 · Cited by 15
Neuropathic Pain: The Scope of the Problem
on behalf of the Neuropathic Pain Special Interest Group of the Italian Society of Neurology (Italian NeuPSIG), Cruccu, G., & Truini, A. (2017) · Pain and Therapy · doi:10.1007/s40122-017-0086-1 · Cited by 11
St-Amant, H., Ware, M. A., Julien, N., & Lacasse, A. (2015) · CMAJ Open · doi:10.9778/cmajo.20140095 · Cited by 10
Self-citationAnalgesic effect of Botulinum toxin in neuropathic pain is sodium channel independent
Kesdoğan, A. B., Neureiter, A., Gaebler, A. J., Kalia, A. K., Körner, J., & Lampert, A. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109967 · Cited by 10
Glial-modulating agents for the treatment of pain: a systematic review
Gilron, I., Xiao, M. Z. X., Carley, M. E., Salter, M. W., Hutchinson, M. R., Moulin, D. E., Moore, A., & Ross‐White, A. (2024) · Pain · doi:10.1097/j.pain.0000000000003447 · Cited by 10
Self-citationLi, M., Fengqun, M., Zhengyao, Z., Mingming, F., Wang, Q., Xiaozhuo, L., Su, D., Han, Q., & Chen, T. (2022) · Spinal Cord · doi:10.1038/s41393-022-00804-y · Cited by 13
Tarride, J., Moulin, D., Lynch, M. E., Clark, A., Stitt, L., Gordon, A., Morley-Forster, P. K., Nathan, H., Smyth, C. E., Toth, C. C., et al. (2015) · Pain Research and Management · doi:10.1155/2015/214873 · Cited by 12
Self-citationRadiologic Findings in Gabapentin-Induced Myositis
Coupal, T. M., Chang, D., Pennycooke, K., Ouellette, H. A., & Munk, P. L. (2017) · Journal of Radiology Case Reports · doi:10.3941/jrcr.v11i4.3092 · Cited by 10
Ari, P., Kars, M. S., Meany, H. J., & Pestieau, S. R. (2017) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000889 · Cited by 10
Interleukin-27 controls basal pain threshold in physiological and pathological conditions
Sasaguri, T., Taguchi, T., Murata, Y., Kobayashi, K., Iizasa, S., Iizasa, E., Tsuda, M., Hirakawa, N., Hara, H., Yoshida, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29398-3 · Cited by 13
Cannabinoids and chronic pelvic pain in women: Focus on endometriosis
Marcu, I., Gee, A. D., & Lynn, B. (2021) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265211011277 · Cited by 12
Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system
Presley, C. S., Abidi, A. H., & Moore, B. M., II (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2015.12.019 · Cited by 10
Filippi, M., & Rocca, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-38621-4_1 · Cited by 14
Ten‐year analgesic utilization patterns and economic implications in Portugal
Duarte, N., Martins, J. P., García‐Pedraza, J. Á., & Santos, M. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16333 · Cited by 11
Chauhan, R., Demetriades, A. K., Boerger, T. F., Lantz, J. M., Treanor, C., Kalsi‐Ryan, S., Kumar, V., Wood, L., Plener, J., Wilson, N., et al. (2025) · Brain and Spine · doi:10.1016/j.bas.2025.104275 · Cited by 9
Pain expectations in neuropathic pain: Is it best to be optimistic?
Bostick, G. P., Kamper, S. J., Haanstra, T. M., Dick, B. D., Stitt, L., Morley-Forster, P., Clark, A. J., Lynch, M. E., Gordon, A., Nathan, H., et al. (2016) · European Journal of Pain · doi:10.1002/ejp.962 · Cited by 9
Self-citationKaboré, J., Pagé, M. G., Martel, M. O., Dassieu, L., Hudspith, M., Moor, G., Sutton, K., Roy, J., Williamson, O. D., & Choinière, M. (2021) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000951 · Cited by 13
Self-citationHassanzadeh, S., Bagheri, S., Ahmadi, S. M., Ahmadi, S. A., Moradishibany, I., Dolatkhah, H., & Reisi, S. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01486-0 · Cited by 13
Hammond, E. A., Pitz, M. W., Lambert, P. J., & Shay, B. L. (2019) · Canadian Journal of Pain · doi:10.1080/24740527.2019.1665992 · Cited by 12
Kamrul, R., Bunka, D., Crawley, A., Schuster, B. G., & LeBras, M. H. (2019) · Europe PMC (PubMed Central) · Cited by 9
Analgesic characteristics of a newly developed α 2 δ ligand, mirogabalin, on inflammatory pain
Komatsu, S., Nakamura, S., Nonaka, T., Yamada, T., & Yamamoto, T. (2021) · Molecular Pain · doi:10.1177/17448069211052167 · Cited by 9
Ogon, I., Takebayashi, T., Miyakawa, T., Iwase, T., Tanimoto, K., Terashima, Y., Jimbo, S., Kobayashi, T., Tohse, N., & Yamashita, T. (2015) · European Journal of Pain · doi:10.1002/ejp.804 · Cited by 9
Cuomo, I., Piacentino, D., Kotzalidis, G. D., Lionetto, L., & Filippis, S. D. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12784 · Cited by 11
Alterations in Spinal Cord Metabolism during Treatment of Neuropathic Pain
Johnson, C. H., Patti, G. J., Courade, J., Shriver, L. P., Hoang, L. T., Manchester, M., & Siuzdak, G. E. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9624-y · Cited by 9
HIV pain management challenges and alternative therapies
Mello, A., & Gravel, T. (2017) · Nursing · doi:10.1097/01.nurse.0000513611.64023.0b · Cited by 8
Ballard, J. E., Pall, P. S., Vardigan, J. D., Zhao, F., Holahan, M. A., Kraus, R. L., Li, Y., Henze, D. A., Houghton, A. K., Burgey, C. S., et al. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02914-9 · Cited by 8
Hébert, H. L., Morales, D. R., Torrance, N., Smith, B. H., & Colvin, L. (2022) · Implementation Science · doi:10.1186/s13012-022-01251-2 · Cited by 9
Farkas, D. J., Inan, S., Heydari, L. N., Johnson, C. T., Zhao, P., Bradshaw, H. B., Ward, S. J., & Rawls, S. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121878 · Cited by 11
Approach to the pharmacological management of chronic pain in patients with an alcohol use disorder
Furlan, A. D., Murphy, L. L., Ng, K., Su, V., Woodworth-Giroux, S., Levy, T. S., & Sproule, B. A. (2015) · Journal of Pain Research · doi:10.2147/jpr.s88900 · Cited by 9
Self-citationIntercostal Neurolysis for The Treatment of Postsurgical Thoracic Pain: a Case Series
Cappellari, A. M., Tiberio, F., Alicandro, G., Spagnoli, D., & Grimoldi, N. (2018) · Muscle & Nerve · doi:10.1002/mus.26298 · Cited by 9
Ballard, J. E., Pall, P. S., Vardigan, J. D., Zhao, F., Holahan, M. A., Zhou, X., Jochnowitz, N., Kraus, R. L., Klein, R. M., Henze, D. A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.786078 · Cited by 9
What are the Treatment Options for Paroxysmal Extreme Pain Disorder?
Suter, M. R. (2015) · Pain Management · doi:10.2217/pmt.15.24 · Cited by 8
Evidence-Based Pharmacotherapy of Chronic Pain
Smith, H. S., Datta, S., & Manchikanti, L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1651-8_28 · Cited by 7
Physiology and Pathology of Aging
Hirsch, C. H., & Hategan, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-67555-8_1 · Cited by 10
Evidence Mapping Based on Systematic Reviews of Cognitive Behavioral Therapy for Neuropathic Pain
Li, C., Hou, W., Ding, D., Yang, Y., Gu, S., & Zhu, Y. (2023) · Neural Plasticity · doi:10.1155/2023/2680620 · Cited by 10
Bittencourt, J. V., Corrêa, L. A., Pagnez, M. A. M., do Rio, J. P. M., Telles, G. F., Mathieson, S., & Nogueira, L. A. C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313025 · Cited by 11
Pharmacologic therapies of pain in patients with spinal cord injury: a systematic review
Asgardoon, M. H., Jazayeri, S. B., Behkar, A., Ohadi, M. A. D., Yarmohammadi, H., Ghodsi, Z., Pomerani, T. I., Mojtahedzadeh, M., & Rahimi‐Movaghar, V. (2022) · Spinal Cord Series and Cases · doi:10.1038/s41394-022-00529-3 · Cited by 8
Expert Consensus on Ion Channel Drugs for Chronic Pain Treatment in China
Ma, K., Cheng, Z., Jiang, H., Lin, Z., Liu, C., Liu, X., Lu, L., Lü, Y., Tao, W., Wang, S., et al. (2024) · Journal of Pain Research · doi:10.2147/jpr.s445171 · Cited by 10
Pharmacologic and Nonpharmacologic Management of Neuropathic Pain
Feldman, A., & Weaver, J. (2024) · Seminars in Neurology · doi:10.1055/s-0044-1791770 · Cited by 8
Cancer Pain Management: Comprehensive Assessment and Nonopioid Analgesics, Part 1
Wickham, R. (2017) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2017.8.5.4 · Cited by 7
Wu, C. L., & Jarvi, K. A. (2018) · Current Urology Reports · doi:10.1007/s11934-018-0811-2 · Cited by 8
Jufriady Ismy, X., Emril, D. R., & Rizkidawati (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.10.070 · Cited by 7
Treatment of Neuropathic Pain in Brachial Plexus Injuries
Sáiz‐Sapena, N., Vanaclocha, V., Ortiz-Criado, J. M., Vanaclocha, L., & Vanaclocha, N. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82084 · Cited by 7
Carvajal, A. M. R., Osorio, C. A. O., Rojas, S. M., & Ibatá, L. (2018) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2018.3673/2018 · Cited by 7
Petzke, F. W., Enax‐Krumova, E., & Häuser, W. (2017) · Der Schmerz · doi:10.1007/s00482-017-0242-x · Cited by 7
Mayo, P., & Walter, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-11775-7_21 · Cited by 7
Lidocaine infusions in chronic pain management: A prospective case series analysis
Vacher, E., Kosela, M., Song-Smith, C., Morell-Ducos, F., & Fayaz, A. (2021) · British Journal of Pain · doi:10.1177/20494637211054198 · Cited by 6
Early optimized pharmacological treatment in patients with depression and chronic pain
Oluboka, O. J., Katzman, M. A., Habert, J., Khullar, A., Oakander, M. A., McIntosh, D., McIntyre, R. S., Soares, C. N., Lam, R. W. M., Klassen, L. J., et al. (2022) · CNS Spectrums · doi:10.1017/s1092852922000128 · Cited by 10
Metadata
- Authors
- Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., Sessle, B., Squire, P., Stinson, J., Taenzer, P., Velly, A., Ware, M., Weinberg, E., & Williamson, O.
- Affiliations
- Victoria Hospital (CA)
- Corresponding author
- Moulin, DE
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 19
- Issue
- 6
- Pages
- 328-335
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- PMC
- PMC4273712
- OpenAlex
- W2206489433
- Cited by
- 529
- References
- 97
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 54 · 2023: 38 · 2022: 38 · 2021: 58 · 2020: 53 · 2019: 53 · 2018: 52 · 2017: 60 · 2016: 50 · 2015: 43
- FWCI
- 34.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pain Research and Management (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship@McGill (McGill) (submittedVersion, cc-by)
- eScholarship@McGill (McGill) (submittedVersion, other-oa)
- Funders
- Neuropathic Pain Special Interest Group of the CPS
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- neuropathic pain, pharmacological management, gabapentinoids, pregabalin, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, tramadol, controlled-release opioids, cannabinoids, methadone, antiepileptic drugs, tapentadol, botulinum toxin, analgesic combination, stepwise treatment, analgesic efficacy and safety
- MeSH terms
- Analgesics, Canada, Humans, Neuralgia, Chronic Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.